ATORVASTATIN IN ACUTE AND CHRONIC KINDS OF ISCHEMIC HEART DISEASE
The review focuses on clinical trials data demonstrating a possibility of effective statin therapy of acute and chronic ischemic heart disease courses. The analysis of maximal dosages of atorvastatin application provided, its early prescription in first 24-96 hours after acute cardiovascular event a...
Main Authors: | V. E. Oleynikov, A. A. Khromova, L. I. Gusakovskaya, N. V. Sergatskaya, E. M. Romanovskaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2015-11-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/463 |
Similar Items
-
ANTIATHEROGENIC AND PLEIOTROPIC ACTIVITY OF VARIOUS DOSES OF ATORVASTATIN IN PATIENTS WITH ISCHEMIC STROKE
by: M. G. Bubnova, et al.
Published: (2013-08-01) -
Statinotherapy – the paradigm of prevention and treatment of atherosclerotic pathology (focus on atorvastatin)
by: R. G. Oganov, et al.
Published: (2006-12-01) -
Atorvastatin: old friend in the light of novel coronavirus infection’s pandemia
by: M. V. Ezhov, et al.
Published: (2022-04-01) -
Cost/effectiveness analysis of atorvastatin in patients with acute coronary syndromes
by: Simona Cammarota, et al.
Published: (2010-06-01) -
Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention
by: M. P. Mal’gina, et al.
Published: (2007-06-01)